Patents by Inventor Tsuyoshi Takato

Tsuyoshi Takato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200147233
    Abstract: It is an object of the present invention to provide a method for killing tumor cells, having a few side effects. The present invention provides a method for killing tumor cells, comprising: (1) a step of allowing an immunotoxin formed by binding an antibody binding to ROBO1 or a fragment thereof to a cytotoxin to come into contact with tumor cells; (2) a step of allowing a photosensitizer that induces photochemical cytoplasmic internalization to come into contact with the tumor cells; and (3) a step of irradiating the tumor cells with a wave length that is effective for activating the sensitizer, so as to kill the cells.
    Type: Application
    Filed: October 3, 2019
    Publication date: May 14, 2020
    Applicant: PhotoQ3 Inc.
    Inventors: Takao HAMAKUBO, Noriko KOMATSU, Kenichi MITSUI, Osamu ARAI, Hiroko IWANARI, Tsuyoshi TAKATO, Takahiro ABE
  • Patent number: 8921038
    Abstract: A method, according to an embodiment, for evaluating a regenerated cartilage includes allowing a group of cells containing auricular chondrocytes to stand in the presence of a culture medium, subsequently collecting at least a portion of a liquid component from the culture medium, measuring the GFAP content of the collected liquid component, and determining whether a regenerated cartilage that has been obtained or can be obtained from the group of cells is suitable for transplantation based on the GFAP content.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: December 30, 2014
    Assignees: Fujisoft Incorporated, The University of Tokyo
    Inventors: Kazuto Hoshi, Tsuyoshi Takato, Motohiro Harai
  • Publication number: 20130302834
    Abstract: A method, according to an embodiment, for evaluating a regenerated cartilage includes allowing a group of cells containing auricular chondrocytes to stand in the presence of a culture medium, subsequently collecting at least a portion of a liquid component from the culture medium, measuring the GFAP content of the collected liquid component, and determining whether a regenerated cartilage that has been obtained or can be obtained from the group of cells is suitable for transplantation based on the GFAP content.
    Type: Application
    Filed: July 19, 2013
    Publication date: November 14, 2013
    Applicants: THE UNIVERSITY OF TOKYO, FUJISOFT INCORPORATED
    Inventors: Kazuto HOSHI, Tsuyoshi Takato, Motohiro Harai
  • Publication number: 20100069455
    Abstract: A method for producing a bone filler basically comprising: a bone model producing step (step 1) for producing a bone model; a figure forming material filling step (step 2) for filling a figure forming material into a bone defect site of the bone model obtained in the bone model producing step; and a bone filler producing step (step 3) for producing a bone filler which is to be filled in a bone defect site based on the figure forming material filled in the bone defect site of the bone model in the figure forming material filling step.
    Type: Application
    Filed: August 20, 2007
    Publication date: March 18, 2010
    Applicants: NEXT21 K.K., THE UNIVERSITY OF TOKYO
    Inventors: Tsuyoshi Takato, Hideto Saijo, Yuchi Tei, Shigeki Suzuki, Koutaro Shimizu, Shinya Wasada
  • Publication number: 20070134793
    Abstract: The object of the invention is to provide a redifferention medium and a redifferention method for making dedifferentiated chondrocyte to be redifferentiated into original chondrocyte, the dedifferentiated chondrocyte having attenuated cartilage characteristics due to dedifferentiation during in vitro culture. Accordingly, the invention provides a redifferention medium which is used for redifferentiating the dedifferentiated chondrocyte into the original chondrocyte, and contains insulin and at least one selected from BMP-2 and analogues thereof. The invention also provides a method for redifferentiating the dedifferentiated chondrocyte into the chondrocyte by culturing the dedifferentiated chondrocyte using the redifferentiation medium. The redifferentiation medium preferably further contains T3.
    Type: Application
    Filed: February 23, 2007
    Publication date: June 14, 2007
    Inventors: Kazuto HOSHI, Yuichi Tei, Hiroshi Kawaguchi, Kozo Nakamura, Tsuyoshi Takato